TNF-α-Induced Secretion of C-C Chemokines Modulates C-C Chemokine Receptor 5 Expression on Peripheral Blood Lymphocytes

Peripheral blood lymphocytes express CCR5, a chemokine receptor for immune cell migration and calcium signaling that serves as an important coreceptor for the HIV. After in vitro stimulation, CCR5 expression is dramatically increased on mature T lymphocytes, especially on the CD45RO+ memory subset. In this study, we report that TNF-α delays the surface expression of CCR5 on PBLs after activation and diminishes CCR5 irrespective of its initial level. Functional loss of CCR5 is reflected in a decreased capability of the treated cells to migrate and signal calcium after MIP-1β stimulation. The effect is mediated via the p80 type II TNF receptor (TNFR2), which induces NF-κB among other factors, leading to an enhanced secretion of the chemokines macrophage-inflammatory protein-1α, macrophage-inflammatory protein-1β, and RANTES. Expression of these chemokines directly down-regulates CCR5. These findings reveal a new regulatory mechanism utilized by activated peripheral T cells to modulate their chemotaxis and potentially other functions mediated by CCR5, including the infection of T lymphocytes by macrophage-tropic HIV strains.

[1]  D. Markovitz,et al.  TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. , 1999, Journal of immunology.

[2]  C. Martínez-A,et al.  Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex. , 1999, Journal of immunology.

[3]  S. Worgall,et al.  Expression and Use of Human Immunodeficiency Virus Type 1 Coreceptors by Human Alveolar Macrophages , 1999, Journal of Virology.

[4]  Antonio Lanzavecchia,et al.  Distinct patterns and kinetics of chemokine production regulate dendritic cell function , 1999, European journal of immunology.

[5]  S. Hanauer,et al.  Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. , 1999, Inflammatory bowel diseases.

[6]  J. Gómez-Reino,et al.  Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. , 1999, Arthritis and rheumatism.

[7]  K. Uhlig,et al.  Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. , 1999, Arthritis and rheumatism.

[8]  D. Weissman,et al.  Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Okumura,et al.  Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. , 1999, International immunology.

[10]  M. Oppermann,et al.  Differential Effects of CC Chemokines on CC Chemokine Receptor 5 (CCR5) Phosphorylation and Identification of Phosphorylation Sites on the CCR5 Carboxyl Terminus* , 1999, The Journal of Biological Chemistry.

[11]  J. Berzofsky,et al.  Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms. , 1999, Journal of immunology.

[12]  M. Lenardo,et al.  NF‐κB regulates Fas / APO‐1 / CD95‐ and TCR‐mediated apoptosis of T lymphocytes , 1999 .

[13]  F. Sánchez‐Madrid,et al.  Similarities and Differences in RANTES- and (AOP)-RANTES–triggered Signals: Implications for Chemotaxis , 1999, The Journal of cell biology.

[14]  E. M. Rogers,et al.  Nuclear factor-kappa B p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene. , 1999, Journal of immunology.

[15]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[16]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[17]  N. Landau,et al.  Functional analysis of the proximal CCR5 promoter. , 1998, AIDS research and human retroviruses.

[18]  B. Levine,et al.  Naı̈ve and Memory CD4 T Cells Differ in Their Susceptibilities to Human Immunodeficiency Virus Type 1 Infection following CD28 Costimulation: Implications for Transmission and Pathogenesis , 1998, Journal of Virology.

[19]  Ping Wang,et al.  Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization , 1998, Journal of cellular biochemistry.

[20]  C. Vita,et al.  Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells , 1998, The Journal of experimental medicine.

[21]  L. Zheng,et al.  Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo. , 1998, Immunity.

[22]  Christoph Schaniel,et al.  Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation , 1998, European journal of immunology.

[23]  H. Marquart,et al.  CC chemokine receptor 5 polymorphism in rheumatoid arthritis. , 1998, The Journal of rheumatology.

[24]  J. Westwick,et al.  Chemokines and T lymphocytes: more than an attraction. , 1998, Immunity.

[25]  D. Littman Chemokine Receptors: Keys to AIDS Pathogenesis? , 1998, Cell.

[26]  M. Mack,et al.  Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.

[27]  A. Sica,et al.  Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. , 1998, Journal of immunology.

[28]  M. Baggiolini Chemokines and leukocyte traffic , 1998, Nature.

[29]  S. Akira,et al.  A novel lipopolysaccharide inducible C‐C chemokine receptor related gene in murine macrophages , 1998, FEBS letters.

[30]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[31]  F. Goebel,et al.  Lack of protection from HIV infection by the mutant HIV coreceptor CCR5 in intravenously HIV infected hemophilia patients. , 1998, Immunobiology.

[32]  Hassan Mohammad Naif,et al.  CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.

[33]  J. Schlessinger,et al.  Signal Transduction Due to HIV-1 Envelope Interactions with Chemokine Receptors CXCR4 or CCR5 , 1997, The Journal of experimental medicine.

[34]  D. Weissman,et al.  Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor , 1997, Nature.

[35]  L. Zheng,et al.  Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. , 1997, Journal of immunology.

[36]  B. Cullen,et al.  Molecular mechanism of desensitization of the chemokine receptor CCR‐5: receptor signaling and internalization are dissociable from its role as an HIV‐1 co‐receptor , 1997, The EMBO journal.

[37]  Jean Salamero,et al.  HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.

[38]  Nancy Sullivan,et al.  CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.

[39]  C. Katlama,et al.  HIV-1 infection in an individual homozygous for CCR5▵32 , 1997, The Lancet.

[40]  C. Winkler,et al.  HIV-1 infection in a man homozygous for CCR5▵32 , 1997, The Lancet.

[41]  C. Katlama,et al.  HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group. , 1997, Lancet.

[42]  A. Fauci,et al.  Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. , 1997, Journal of immunology.

[43]  C. Mackay,et al.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Giacca,et al.  C–C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T Cells , 1997, The Journal of experimental medicine.

[45]  A. Sica,et al.  Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes , 1997, The Journal of experimental medicine.

[46]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[47]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[48]  Steven M. Wolinsky,et al.  The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.

[49]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[50]  T. Schall,et al.  RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells , 1996, The Journal of experimental medicine.

[51]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[52]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[53]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[54]  J. Boss,et al.  TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene. , 1996, Immunity.

[55]  D. Taub,et al.  β Chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production , 1996, Journal of leukocyte biology.

[56]  George Kollias,et al.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.

[57]  M. Lenardo,et al.  Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.

[58]  B. Premack,et al.  Activation of dual T cell signaling pathways by the chemokine RANTES. , 1995, Science.

[59]  P. Murphy,et al.  Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.

[60]  J. Woody,et al.  Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis , 1994, The Lancet.

[61]  M. Baum,et al.  Endometrial cancer during tamoxifen treatment , 1994, The Lancet.

[62]  R. Binns,et al.  RANTES and chemokines in rheumatoid arthritis , 1994, The Lancet.

[63]  A. Hajeer,et al.  RANTES role in rheumatoid arthritis , 1994, The Lancet.

[64]  K. Tracey,et al.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. , 1994, Annual review of medicine.

[65]  P. Murphy The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[66]  M. Plumb,et al.  C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene , 1993, Molecular and cellular biology.

[67]  A. Fischer,et al.  Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56Ick in human CD4 T lymphocytes , 1993, European journal of immunology.

[68]  P. Vassalli,et al.  The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.

[69]  L. Gooding,et al.  A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.

[70]  A. Israël,et al.  Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. , 1989, Journal of immunology.

[71]  T. Mosmann,et al.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies , 1987, The Journal of experimental medicine.

[72]  B. Bonavida,et al.  Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor. , 1987, Journal of immunology.

[73]  J. Vilček,et al.  Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. , 1987, Journal of immunology.

[74]  R. Coffman,et al.  Two types of mouse helper T-cell clone Implications for immune regulation. , 1987, Immunology today.

[75]  S. Liang,et al.  Mediation of mouse natural cytotoxic activity by tumour necrosis factor , 1986, Nature.

[76]  H. Holtmann,et al.  Tumor necrosis factor induction by Sendai virus. , 1986, Journal of immunology.